MinervaBMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c3683 (Published 13 July 2010) Cite this as: BMJ 2010;341:c3683
View Full Text
- Markus Braun-Falco, assistant professor,
- Christian Kunte, assistant professor
- 1Department of Dermatology and Allergology, Ludwig-Maximilians-Universität, 80337 Munich, Germany.
A 34 year old woman with a history of rheumatoid arthritis was treated with sulfasalazine, chloroquine, prednisolone, methotrexate, and nine cycles of abatacept infusions. Over the …